We have noted that different liver cancer cell lines responded differently to E2 treatment, hence we examined the expression levels of CYP1A2 and COMT in these cell lines but didn’t get meaningful results to explain the phenomena. This evidence concerns the gene CYP1A2 and liver cancer.